United States · Platforms & data · Zacks Investment Research

HIMS Partners With Lilly to Offer FDA-Approved Weight-Loss Drugs

Published by Zacks Investment Research · United States 1 h ago

Read the full article on Zacks Investment Research Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (news.google.com)

Also worth reading

Carrier Global Sees $3 Billion in Data Center Sales as Cooling Orders Surge 350%

Appili Therapeutics Inc. reports 1H results

How low does Nvidia’s stock need to go before it’s a screaming bargain?

The Motley Fool

3 Unstoppable Memory Stocks to Buy Hand Over Fist in 2027

What's Going On With Lam Research Stock Friday?

US FTC sues to block Cencora’s $3.5 billion sale of veterinary unit to Covetrus